# A Study of Dulaglutide in Healthy Participants

> **NCT03363906** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dulaglutide (Reference)
- **DRUG:** Dulaglutide (Test)

## Key facts

- **NCT ID:** NCT03363906
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-07
- **Primary completion:** 2018-06-06
- **Final completion:** 2018-06-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363906, "A Study of Dulaglutide in Healthy Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03363906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*